Convention calendar
This is an archived article that was published on sltrib.com in 2013, and information in the article may be outdated. It is provided only for personal research purposes and may not be reprinted.

Sunday

The Grout Doctor Global Franchise Corp.

Annual Convention

DoubleTree Suites by Hilton Salt Lake City

Attendance • 60

Runs through • Sunday

Wednesday

Association of Medical Illustrators

Annual Meeting

Sheraton Salt Lake City Hotel

Attendance • 350

Runs through • Saturday

Equality Federation

2013 Summer Meeting

Sheraton Salt Lake City Hotel

Attendance • 150

Runs through • Saturday

Thursday

Jewel Kade

2013 Annual Convention

Little America Hotel

Attendance • 400

Runs through • Saturday

Economic Calendar

New economic numbers to be released this week include:

Monday

National Association of Realtors • Existing home sales for June

Wednesday

Commerce Department • New home sales for June

Thursday

Labor Department • Weekly jobless claims

Freddie Mac • Weekly mortgage rates

Commerce Department • Durable goods for June

IPOs Planned

Initial public offerings scheduled to debut next week as provided by Renaissance Capital, Greenwich, Conn., and SEC filings.

Agios Pharmaceuticals Inc. • Cambridge, Mass., 5 million shares, priced $14 to $16, managed by J.P. Morgan, and Goldman Sachs. Proposed Nasdaq symbol AGIO. Business: Biotech developing metabolic treatments for cancer and rare genetic diseases.

Cellular Dynamics International Inc. • Madison, Wisc., 3.8 million shares, priced $12 to $14, managed by J.P. Morgan. Proposed Nasdaq symbol ICEL. Business: Develops and manufactures functioning human cells in large quantities.

Conatus Pharmaceuticals Inc. • San Diego, 5 million shares, priced $10 to $12, managed by Stifel and Piper Jaffray. Proposed Nasdaq symbol CNAT. Business: Biotech focused on the development of novel medicines to treat liver disease.

Heat Biologics Inc. • Chapel Hill, N.C., 2.3 million shares, priced $10 to $12, managed by Aegis Capital. Proposed Nasdaq symbol HTBX. Business: Developing cellular therapeutic vaccines for cancer therapy.

Jones Energy Inc. • Austin, Texas, 14 million shares, priced $17 to $19, managed by J.P. Morgan, Barclays, and Wells Fargo. Proposed NYSE symbol JONE. Business: Oil and gas E&P focused on the Anadarko and Arkoma basins of Texas and Oklahoma.

Liquid Holdings Group LLC • New York, 5 million shares, priced $9 to $11, managed by Sandler O'Neill. Proposed Nasdaq symbol LIQD. Business: Provides an integrated software platform for hedge funds and asset managers.

Marlin Midstream Partners LP • Houston, 6.25 million shares, priced $19 to $21, managed by Stifel, Baird, and Oppenheimer. Proposed Nasdaq symbol FISH. Business: Owns and operates midstream energy assets and provides gathering, transportation, treating and processing services for natural gas companies.

Onconova Therapeutics Inc. • Newtown, Pa., 4.6 million shares, priced $12 to $14, managed by Citigroup and Leerink Swann. Proposed Nasdaq symbol ONTX. Business: Biotech focused on developing novel small molecule drug candidates for cancer.

Phillips 66 Partners LP • Houston, 15 million shares, priced $19 to $21, managed by J.P. Morgan and Morgan Stanley. Proposed NYSE symbol PSXP. Business: Phillips 66-backed limited partnership that owns pipeline and logistics assets.

WCI Communities Inc. • Bonita Springs, Fla., 8.4 million shares, priced $21 to $23, managed by Citigroup, Credit Suisse, and J.P. Morgan. Proposed NYSE symbol WCIC. Business: Develops luxury residential communities and homes in coastal Florida.